J Neurol Surg A Cent Eur Neurosurg 2023; 84(02): 157-166
DOI: 10.1055/a-1698-6212
Original Article

Comparison of Two Drainage Systems on Chronic Subdural Hematoma Recurrence

1   Division of Neurosurgery, Department of Surgery, Hamilton General Hospital, Hamilton, Ontario, Canada
2   King Faisal Medical City for Southern Regions, Abha, Saudi Arabia
,
Nirmeen Zagzoog
1   Division of Neurosurgery, Department of Surgery, Hamilton General Hospital, Hamilton, Ontario, Canada
,
Nimita Patel
3   Department of Health, Evidence and Impact, McMaster University, Ontario, Canada
,
Amanda Martyniuk
1   Division of Neurosurgery, Department of Surgery, Hamilton General Hospital, Hamilton, Ontario, Canada
,
Sheila Singh
1   Division of Neurosurgery, Department of Surgery, Hamilton General Hospital, Hamilton, Ontario, Canada
,
Forough Farrokhyar
3   Department of Health, Evidence and Impact, McMaster University, Ontario, Canada
,
Arunachala Trivedi
4   Michael G. DeGroote School of Medicine, McMaster University, Ontario, Canada
,
Mazen Alotaibi
1   Division of Neurosurgery, Department of Surgery, Hamilton General Hospital, Hamilton, Ontario, Canada
,
Almunder Algird
1   Division of Neurosurgery, Department of Surgery, Hamilton General Hospital, Hamilton, Ontario, Canada
› Author Affiliations

Abstract

Background Chronic subdural hematoma (CSDH) is a common type of intracranial hemorrhage, especially among the elderly, with a recurrence rate as high as 33%. Little is known about the best type of drainage system and its relationship with recurrence. In this study, we compare the use of two drainage systems on the recurrence rate of CSDH.

Methods We retrospectively analyzed the charts of 172 CSDH patients treated with bedside twist drill craniostomy (TDC) and subdural drain insertion. Patients were divided into two groups: group A (n = 123) received a pediatric size nasogastric tube [NGT]), whereas group B (n = 49) had a drain commonly used for external ventricular drainage (EVD). Various demographic and radiologic data were collected. Our main outcome was recurrence, defined as symptomatic re-accumulation of hematoma on the previously operated side within 3 months.

Results In all, 212 cases of CSDH were treated in 172 patients. The majority of patients were male (78%) and had a history of previous head trauma (73%). Seventeen cases had recurrence, 11 in group A and 6 in group B. The use of antiplatelet and anticoagulation agents was associated with recurrence (p = 0.038 and 0.05, respectively). There was no difference between both groups in terms of recurrence (odds ratio [OR] = 1.42; 95% confidence interval [CI]: 0.49–4.08; p = 0.573).

Conclusion CSDH is a common disease with a high rate of recurrence. Although using a drain postoperatively has shown to reduce the incidence of recurrence, little is known about the best type of drain to use. Our analysis showed no difference in the recurrence rate between using the pediatric size NGT and the EVD catheter post-TDC.



Publication History

Received: 19 March 2021

Accepted: 15 November 2021

Accepted Manuscript online:
16 November 2021

Article published online:
25 February 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Yang W, Huang J. Chronic subdural hematoma: epidemiology and natural history. Neurosurg Clin N Am 2017; 28 (02) 205-210
  • 2 Uno M, Toi H, Hirai S. Chronic subdural hematoma in elderly patients: is this disease benign?. Neurol Med Chir (Tokyo) 2017; 57 (08) 402-409
  • 3 West LA, Cole S, Goodkind D, He W. 65+ in the United States: 2010. Census.gov. 2014. Updated June 30, 2014. Accessed January 30 2021 at: https://www.census.gov/library/publications/2014/demo/p23-212.html
  • 4 Lee K-S. History of chronic subdural hematoma. Korean J Neurotrauma 2015; 11 (02) 27-34
  • 5 D'Errico AP, German WJ. Chronic subdural hematoma. Yale J Biol Med 1930; 3 (01) 11-20
  • 6 Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ. Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation 2017; 14 (01) 108
  • 7 Tanweer O, Frisoli FA, Bravate C. et al. Tranexamic acid for treatment of residual subdural hematoma after bedside twist-drill evacuation. World Neurosurg 2016; 91: 29-33
  • 8 Thotakura AK, Marabathina NR. Nonsurgical treatment of chronic subdural hematoma with steroids. World Neurosurg 2015; 84 (06) 1968-1972
  • 9 Shakur H, Roberts I, Bautista R. et al; CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376 (9734): 23-32
  • 10 Fountas K, Kotlia P, Panagiotopoulos V, Fotakopoulos G. The outcome after surgical vs nonsurgical treatment of chronic subdural hematoma with dexamethasone. Interdiscip Neurosurg 2019; 16: 70-74
  • 11 Yadav YR, Parihar V, Namdev H, Bajaj J. Chronic subdural hematoma. Asian J Neurosurg 2016; 11 (04) 330-342
  • 12 You W, Zhu Y, Wang Y. et al. Prevalence of and risk factors for recurrence of chronic subdural hematoma. Acta Neurochir (Wien) 2018; 160 (05) 893-899
  • 13 Desai VR, Scranton RA, Britz GW. Management of recurrent subdural hematomas. Neurosurg Clin N Am 2017; 28 (02) 279-286
  • 14 Amirjamshidi A, Abouzari M, Eftekhar B. et al. Outcomes and recurrence rates in chronic subdural haematoma. Br J Neurosurg 2007; 21 (03) 272-275
  • 15 Escosa Baé M, Wessling H, Salca HC, de Las Heras Echeverría P. Use of twist-drill craniostomy with drain in evacuation of chronic subdural hematomas: independent predictors of recurrence. Acta Neurochir (Wien) 2011; 153 (05) 1097-1103
  • 16 Andersen-Ranberg NC, Debrabant B, Poulsen FR, Bergholt B, Hundsholt T, Fugleholm K. The Danish chronic subdural hematoma study-predicting recurrence of chronic subdural hematoma. Acta Neurochir (Wien) 2019; 161 (05) 885-894
  • 17 Okano A, Oya S, Fujisawa N. et al. Analysis of risk factors for chronic subdural haematoma recurrence after burr hole surgery: optimal management of patients on antiplatelet therapy. Br J Neurosurg 2014; 28 (02) 204-208
  • 18 Chon KH, Lee JM, Koh EJ, Choi HY. Independent predictors for recurrence of chronic subdural hematoma. Acta Neurochir (Wien) 2012; 154 (09) 1541-1548
  • 19 Jeong SI, Kim SO, Won YS, Kwon YJ, Choi CS. Clinical analysis of risk factors for recurrence in patients with chronic subdural hematoma undergoing burr hole trephination. Korean J Neurotrauma 2014; 10 (01) 15
  • 20 Jamjoom AAB, Joannides AJ, Poon MTC. et al; British Neurosurgical Trainee Research Collaborative. Prospective, multicentre study of external ventricular drainage-related infections in the UK and Ireland. J Neurol Neurosurg Psychiatry 2018; 89 (02) 120-126
  • 21 Oh CW. Erratum: Risk factor analysis for the recurrence of chronic subdural hematoma: a review of 368 consecutive surgical cases. Korean J Neurotrauma 2017; 13 (01) 61
  • 22 Kim SU, Lee DH, Kim YI, Yang SH, Sung JH, Cho CB. Predictive factors for recurrence after burr-hole craniostomy of chronic subdural hematoma. J Korean Neurosurg Soc 2017; 60 (06) 701-709
  • 23 Gelabert-Gonzalez M, Aran-Echabe E. Can recurrence of chronic subdural hematoma be predicted?. J Neurol Surg A Cent Eur Neurosurg 2014; 75 (05) 407
  • 24 Bartek Jr J, Sjåvik K, Kristiansson H. et al. Predictors of recurrence and complications after chronic subdural hematoma surgery: a population-based study. World Neurosurg 2017; 106: 609-614
  • 25 Leroy HA, Aboukaïs R, Reyns N. et al. Predictors of functional outcomes and recurrence of chronic subdural hematomas. J Clin Neurosci 2015; 22 (12) 1895-1900
  • 26 Almenawer SA, Farrokhyar F, Hong C. et al. Chronic subdural hematoma management: a systematic review and meta-analysis of 34,829 patients. Ann Surg 2014; 259 (03) 449-457
  • 27 Santarius T, Kirkpatrick PJ, Ganesan D. et al. Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial. Lancet 2009; 374 (9695): 1067-1073
  • 28 Alcalá-Cerra G, Young AMH, Moscote-Salazar LR, Paternina-Caicedo A. Efficacy and safety of subdural drains after burr-hole evacuation of chronic subdural hematomas: systematic review and meta-analysis of randomized controlled trials. World Neurosurg 2014; 82 (06) 1148-1157
  • 29 Won SY, Zagorcic A, Dubinski D. et al. Excellent accuracy of ABC/2 volume formula compared to computer-assisted volumetric analysis of subdural hematomas. PLoS One 2018; 13 (06) e0199809
  • 30 Gernsback J, Kolcun JPG, Jagid J. To drain or two drains: recurrences in chronic subdural hematomas. World Neurosurg 2016; 95: 447-450
  • 31 Sarica C, Ozgunduz A, Ucler N, Dolas I, Kilinc S. Surgical drains in chronic subdural hematoma surgery: from the cheapest to the most expensive drains. World Neurosurg 2018; 112: 284-286
  • 32 Lee GY, Oh CH, Shim YS. et al. Comparison of drainage volume of chronic subdural hematoma according to drainage catheter type. Yonsei Med J 2013; 54 (05) 1091-1097
  • 33 Wang K, Chen D, Cao X, Gao L. A prospective comparative study of twist drill craniostomy versus burr hole craniostomy in patients with chronic subdural hematoma. Turk Neurosurg 2017; 27 (01) 60-65
  • 34 Mehta V, Harward SC, Sankey EW, Nayar G, Codd PJ. Evidence based diagnosis and management of chronic subdural hematoma: a review of the literature. J Clin Neurosci 2018; 50: 7-15
  • 35 Chavakula V, Yan SC, Huang KT. et al. Subdural pneumocephalus aspiration reduces recurrence of chronic subdural hematoma. Oper Neurosurg (Hagerstown) 2020; 18 (04) 391-397
  • 36 Pan Z, Bao J, Wei S. Efficacy of the direct aspiration-irrigation maneuver for the treatment of chronic subdural hematoma: a single hospital's experience. Cureus 2021; 13 (07) e16231
  • 37 Tosaka M. Letter: Subdural pneumocephalus aspiration reduces recurrence of chronic subdural hematoma. Oper Neurosurg 2021; 21 (01) E67-E68
  • 38 Kitya D, Punchak M, Abdelgadir J, Obiga O, Harborne D, Haglund MM. Causes, clinical presentation, management, and outcomes of chronic subdural hematoma at Mbarara Regional Referral Hospital. Neurosurg Focus 2018; 45 (04) E7
  • 39 Kale A, Öz İİ, Gün EG, Kalaycı M, Gül Ş. Is the recurrence rate of chronic subdural hematomas dependent on the duration of drainage?. Neurol Res 2017; 39 (05) 399-402
  • 40 Juković MF, Stojanović DB. Midline shift threshold value for hemiparesis in chronic subdural hematoma. Srp Arh Celok Lek 2015; 143 (7–8): 386-390
  • 41 World Health Organization. Falls. Updated January 16, 2018. Accessed July 7, 2020 at: https://www.who.int/news-room/fact-sheets/detail/falls
  • 42 Wang H, Zhang M, Zheng H. et al. The effects of antithrombotic drugs on the recurrence and mortality in patients with chronic subdural hematoma: a meta-analysis. Medicine (Baltimore) 2019; 98 (01) e13972
  • 43 Poon MTC, Al-Shahi Salman R. Association between antithrombotic drug use before chronic subdural haematoma and outcome after drainage: a systematic review and meta-analysis. Neurosurg Rev 2018; 41 (02) 439-445
  • 44 Poon MTC, Rea C, Kolias AG, Brennan PM. British Neurosurgical Trainee Research Collabroative. Influence of antiplatelet and anticoagulant drug use on outcomes after chronic subdural hematoma drainage. J Neurotrauma 2021; 38 (08) 1177-1184
  • 45 Wang Y, Zhou J, Fan C. et al. Influence of antithrombotic agents on the recurrence of chronic subdural hematomas and the quest about the recommencement of antithrombotic agents: a meta-analysis. J Clin Neurosci 2017; 38: 79-83
  • 46 Nathan S, Goodarzi Z, Jette N, Gallagher C, Holroyd-Leduc J. Anticoagulant and antiplatelet use in seniors with chronic subdural hematoma: systematic review. Neurology 2017; 88 (20) 1889-1893
  • 47 Chari A, Clemente Morgado T, Rigamonti D. Recommencement of anticoagulation in chronic subdural haematoma: a systematic review and meta-analysis. Br J Neurosurg 2014; 28 (01) 2-7